Category & Conditions: Cancer
Study Phase : 1/2
Medicine: BAVENCIO(AVELUMAB), MEKTOVI® TABLETS(BINIMETINIB), Talzenna (talazoparib)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: EUCRISA™(CRISABOROLE)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1/2
Medicine: MEKTOVI® TABLETS(BINIMETINIB), OPDIVO®(NIVOLUMAB), YERVOY®(IPILIMUMAB)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 4
Medicine: MYLOTARG™(GEMTUZUMAB OZOGAMICIN FOR INJECTION)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: Bavencio (avelumab), INLYTA®(AXITINIB)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 2
Medicine: brepocitinib (PF-06700841), ritlecitinib (PF-06651600)
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 1
Medicine: danuglipron (PF-06882961)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: Dekavil
PrintDownloadCategory & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: Eucrisa (crisaborole)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Ibrance (palbociclib)
PrintDownloadCategory & Conditions: Diabetes and Metabolic Disorders
Study Phase : 2
Medicine: PF-06835919
PrintDownloadCategory & Conditions: Coronavirus Disease (COVID-19)
Study Phase : 3
Medicine: PF-07302048 (BNT162)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2
Medicine: ritlecitinib (PF-06651600) / brepocitinib (PF-06700841)
PrintDownloadCategory & Conditions: Cancer
Study Phase : 3
Medicine: Talzenna (talazoparib)
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 2/3
Medicine: PF-06651600
PrintDownloadCategory & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: Enbrel®/Etanercept
PrintDownloadCategory & Conditions: Cancer
Study Phase : 1
Medicine: PF-06753512
PrintDownload